TELA Bio, Inc. — Director's Dealing 2019

Nov 7, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TELA Bio, Inc. (TELA)
CIK: 0001561921
Period of Report: 2019-11-07

Reporting Person: Burgess Vincent J (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.45	2023-04-11	Common Stock (4860)		Direct
Stock Option (right to buy)	$5.93	2025-07-23	Common Stock (11047)		Direct
Stock Option (right to buy)	$5.93	2028-02-28	Common Stock (3015)		Direct
Stock Option (right to buy)	$13.00	2029-11-07	Common Stock (5331)		Direct

Footnotes

F1: The option vested 25% on February 28, 2019, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

F2: The option vests in 36 equal monthly installments on each monthly anniversary of November 7, 2019, subject to the Reporting Person's continuous service with the Issuer.